BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1557801)

  • 1. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis.
    Baginski I; Chemin I; Hantz O; Pichoud C; Jullien AM; Chevre JC; Li JS; Vitvitski L; Sninsky JJ; Trepo C
    Transfusion; 1992; 32(3):215-20. PubMed ID: 1557801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.
    Mosley JW; Huang W; Stram DO; Nowicki MJ; Hollinger FB; Aach RD; Stevens CE; Barbosa LH; Nemo GJ
    Transfusion; 1996 Sep; 36(9):776-81. PubMed ID: 8823449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients.
    Mosley JW; Stevens CE; Aach RD; Hollinger FB; Mimms LT; Solomon LR; Barbosa LH; Nemo GJ
    Transfusion; 1995 Jan; 35(1):5-12. PubMed ID: 7998069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase.
    Sankary TM; Yang G; Romeo JM; Ulrich PP; Busch MP; Rawal BD; Vyas GN
    Transfusion; 1994 Aug; 34(8):656-60. PubMed ID: 8073480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of hepatitis C virus (HCV)-RNA and--antibody as markers of infection and predictors of infectivity.
    Beardsley AM; LaBrooy JT; Rozen L; Gowans EJ
    Aust N Z J Med; 1994 Apr; 24(2):182-7. PubMed ID: 8042947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.
    Busch MP; Korelitz JJ; Kleinman SH; Lee SR; AuBuchon JP; Schreiber GB
    Transfusion; 1995; 35(11):903-10. PubMed ID: 8604486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.
    Koziol DE; Holland PV; Alling DW; Melpolder JC; Solomon RE; Purcell RH; Hudson LM; Shoup FJ; Krakauer H; Alter HJ
    Ann Intern Med; 1986 Apr; 104(4):488-95. PubMed ID: 3006567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.
    Stevens CE; Aach RD; Hollinger FB; Mosley JW; Szmuness W; Kahn R; Werch J; Edwards V
    Ann Intern Med; 1984 Dec; 101(6):733-8. PubMed ID: 6437308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.
    Allain JP; Hewitt PE; Tedder RS; Williamson LM
    Br J Haematol; 1999 Oct; 107(1):186-95. PubMed ID: 10520040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants.
    Kojima M; Shimizu M; Tsuchimochi T; Koyasu M; Tanaka S; Iizuka H; Tanaka T; Okamoto H; Tsuda F; Miyakawa Y
    Vox Sang; 1991; 60(1):34-9. PubMed ID: 2053327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
    Ebeling F
    Vox Sang; 1991; 60(4):219-24. PubMed ID: 1681620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission.
    Watanabe M; Ohkoshi S; Tawaraya H; Miyajima T; Shimotohno K; Kamimura T; Asakura H
    Transfusion; 1994 Feb; 34(2):125-9. PubMed ID: 7508643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HBV C gene mutation in the transmission from father to infant].
    Wang SS; Li MM; Peng GF; Li WL; Jin HL; Xiao H; Zeng NH; Wang ZB; Huang JL; Su JX
    Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):845-8. PubMed ID: 14728893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission.
    Jullien AM; Couroucé AM; Massari V; Maniez M; Finetti P; Brevière D; Girard M; Andréani T; Habibi B
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):668-72. PubMed ID: 8243482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen.
    Laperche S; Guitton C; Smilovici W; Courouce AM
    Vox Sang; 2001 Feb; 80(2):90-4. PubMed ID: 11378970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.